← All organizations

Lumos Pharma

For profit

Also known as: Lumos Pharma

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 30, 2026

Acquired by NewLink Genetics Inc on Sep 30, 2019

Timeline

2010s

Jun 1, 2011
Lumos Pharma— Founded
Sep 30, 2019
NewLink Genetics Inc— Acquired By

Drugs by trial phase (3 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

somatropin

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT07129759Lead sponsorPhase 3Sep 30, 2026
NCT06948214Lead sponsorPhase 3Oct 31, 2025
NCT05796440Lead sponsorPhase 2Aug 1, 2023
NCT05469490CollaboratorPhase 1Oct 31, 2022
NCT05250063Lead sponsorPhase 2Feb 18, 2022
NCT04806854Lead sponsorPhase 2Jun 30, 2021
NCT04614337Lead sponsorPhase 2Oct 7, 2020

Details

Founded: Austin, TX, US Jun 1, 2011
Last known activity: Sep 30, 2026